Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 16INDUSTRY 8NIH 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Lymphoma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 22Burkitt Lymphoma 17Central Nervous System Neoplasms 15Neuroblastoma 13Lymphoma, Large B-Cell, Diffuse 13Sarcoma 11Lymphoma, Follicular 11Hodgkin Disease 10Brain Neoplasms 10Medulloblastoma 9Rhabdomyosarcoma 8Wilms Tumor 7Leukemia, Biphenotypic, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large-Cell, Anaplastic 6Oligodendroglioma 5Lymphoma, Mantle-Cell 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Multiple Myeloma 4Malignant mesenchymal tumor 4Dendritic Cell Sarcoma, Interdigitating 4Astrocytoma 4Waldenstrom Macroglobulinemia 3Sarcoma, Ewing 3Rhabdoid Tumor 3Lymphoma, Large-Cell, Immunoblastic 3Ganglioneuroblastoma 3

Interventions

Vinorelbine 4Dexamethasone 4Filgrastim 3Vincristine 2Peripheral Blood Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Fenretinide 2Etoposide 2Cytarabine 2Carmustine 2Bortezomib 2zanubrutinib 1relatlimab 1pomalidomide 1pegaspargase 1palbociclib 1liposomal amphotericin B 1ixazomib 1irinotecan sucrosofate 1interferon gamma-1b 1interferon gamma, Cys(-3), Tyr(-2), Cys(-1)- 1imetelstat 1etoposide phosphate 1elotuzumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carfilzomib 1auricularum 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Recurrence × Vincristine × Clear all
NCT03792256 2025-03-21

Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

Children's Oncology Group

Phase 1 Completed
12 enrolled 24 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Recurrence, Leukemia, T-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02163356 2022-03-31

SPOC2013-001

South Plains Oncology Consortium

Phase 1 Terminated
4 enrolled
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡